Scarica l'app Stockscreener
11.17
5.02%
-0.59
Precedente Chiudi:
$11.76
Aprire:
$11.73
Volume 24 ore:
106.18K
Relative Volume:
0.22
Capitalizzazione di mercato:
$105.19M
Reddito:
-
Utile/perdita netta:
$-81.17M
Rapporto P/E:
-1.1022
EPS:
-10.1344
Flusso di cassa netto:
$-82.84M
1 W Prestazione:
-11.14%
1M Prestazione:
+24.25%
6M Prestazione:
-40.99%
1 anno Prestazione:
-61.59%
Intervallo 1D:
$11.06
$11.87
Intervallo di 1 settimana:
$10.81
$12.81
Portata 52W:
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
Nome
Korro Bio Inc
Settore
Industria
Telefono
617-468-1999
Indirizzo
60 FIRST STREET, CAMBRIDGE
Compare KRRO vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
11.17 | 110.75M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-29 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2026-01-29 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2026-01-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2026-01-28 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2026-01-28 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-11-13 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Iniziato | Chardan Capital Markets | Buy |
| 2025-01-10 | Iniziato | Oppenheimer | Outperform |
| 2024-10-21 | Iniziato | Raymond James | Strong Buy |
| 2024-08-14 | Iniziato | William Blair | Outperform |
| 2024-03-28 | Reiterato | H.C. Wainwright | Buy |
| 2024-02-27 | Iniziato | BMO Capital Markets | Outperform |
| 2023-12-04 | Iniziato | H.C. Wainwright | Buy |
| 2023-11-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-11-10 | Iniziato | Piper Sandler | Overweight |
| 2023-02-15 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Downgrade | Cowen | Outperform → Market Perform |
| 2021-09-22 | Downgrade | Goldman | Buy → Neutral |
| 2021-01-27 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Iniziato | B. Riley Securities | Buy |
| 2020-07-14 | Iniziato | Oppenheimer | Outperform |
| 2020-05-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Iniziato | Cowen | Outperform |
| 2019-10-28 | Iniziato | Goldman | Buy |
| 2019-10-28 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Korro Bio Inc Borsa (KRRO) Ultime notizie
Is Korro Bio Inc. stock a good dividend stockQuarterly Investment Review & AI Powered Buy and Sell Recommendations - mfd.ru
We Think Korro Bio (NASDAQ:KRRO) Needs To Drive Business Growth Carefully - Yahoo Finance
Can Korro Bio Inc. disrupt its industryMarket Growth Summary & Weekly Market Pulse Updates - mfd.ru
Korro Bio, Inc. (NASDAQ:KRRO) Given Average Rating of "Hold" by Brokerages - MarketBeat
H.C. Wainwright Flag KRRO-121 as Independent Value Driver for Korro Bio, Inc. (KRRO) - MSN
Is FHN.PRB stock a good pick for beginnersJuly 2025 Analyst Calls & Precise Entry and Exit Recommendations - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Korro Bio (KRRO) and AstraZeneca (AZN) - The Globe and Mail
HC Wainwright Brokers Lower Earnings Estimates for Korro Bio - Defense World
Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength? - Nasdaq
Korro Bio Analyst Day: KRRO-121 RNA-Editing Candidate Targets Ammonia Control in UCD and HE - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Pfizer (PFE) and Alpha Teknova (TKNO) - The Globe and Mail
Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential By Investing.com - Investing.com Nigeria
Korro Bio's KRRO-121 Receives Strong Analyst Upgrades - intellectia.ai
Korro Bio Shares Rise After Piper Sandler, HC Wainwright Upgrades - marketscreener.com
Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential - Investing.com Canada
Piper Sandler Upgrades Korro Bio to Overweight From Neutral, Adjusts Price Target to $30 From $11 - marketscreener.com
HC Wainwright Upgrades Korro Bio to Buy From Neutral, Price Target is $20 - marketscreener.com
This Fortinet Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
HC Wainwright & Co. Upgrades Korro Bio (KRRO) - Nasdaq
KRRO Shares Jump 13% On Analyst UpgradesWhat's Driving The Optimism? - Mena FN
Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment - Investing.com Nigeria
Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential - Investing.com India
Oppenheimer Upgrades Korro Bio (KRRO) - Nasdaq
Korro Bio Shares Rise After Oppenheimer Upgrade - marketscreener.com
Raymond James reiterates Market Perform rating on Korro Bio stock By Investing.com - Investing.com India
Cantor Fitzgerald Upgrades Korro Bio to Overweight From Neutral - marketscreener.com
William Blair reiterates Market Perform rating on Korro Bio stock By Investing.com - Investing.com Canada
Raymond James reiterates Market Perform rating on Korro Bio stock - Investing.com
William Blair reiterates Market Perform rating on Korro Bio stock - Investing.com
Cantor Fitzgerald upgrades Korro Bio stock to Overweight on UCD program By Investing.com - Investing.com South Africa
Cantor Fitzgerald upgrades Korro Bio stock to Overweight on UCD program - Investing.com
Korro Bio stock holds steady as Jones Trading reiterates Hold rating - Investing.com
Clear Street raises Korro Bio stock price target to $10 on new lead program - Investing.com Nigeria
Clear Street raises Korro Bio stock price target to $10 on new lead program By Investing.com - Investing.com South Africa
Korro Bio Showcases KRRO-121 RNA Editing Program Progress - TipRanks
Korro Bio, Inc. Unveils KRRO-121 as a Potential First-in-Class Treatment - TradingView
Investor Mood: Does Red Rock Resorts Inc have strong fundamentalsJuly 2025 Patterns & Reliable Intraday Trade Alerts - baoquankhu1.vn
Moving Averages: Will Korro Bio Inc benefit from green energy policiesMarket Sentiment Summary & Low Risk High Win Rate Picks - baoquankhu1.vn
Growth Recap: Should I buy Korro Bio Inc stock now2025 Volume Leaders & Safe Capital Growth Stock Tips - baoquankhu1.vn
Korro to Host Virtual Analyst Day on January 27, 2026 - The Manila Times
Korro Bio Inc Azioni (KRRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):